Linnea SA

As the holiday season approaches, we at Linnea extend our warmest wishes to you. Our seasonal greetings, shared in multiple languages, embody the rich diversity and unity that make this time of year so special: https://lnkd.in/dtc_XisZ This period reflects our core values: respect for individuals, embracing diversity, and a commitment to continuous improvement. And, likewise, respect for Nature, our muse and the very essence of the high quality botanical APIs we make. In the spirit of giving, Linnea is supporting the reconstruction of Vallemaggia, a region near our Swiss headquarters recently devastated by natural disasters. We encourage everyone to join us in aiding the local communities' recovery. ➡️ Learn more and donate: https://lnkd.in/d4czCJCt Here's to a joyous conclusion of 2024 and a bright beginning to 2025 ❄️ 🎄 Happy Holidays! #Linnea #LinneaPharma #HappyHolidays2024 #SeasonGreetings #LinneaFamily #BotanicalAPIs #SwissQuality #NatureInspired

We are pleased to announce the completion of our inaugural ESG Report for 2023—a significant achievement that underscores our unwavering commitment to sustainability. This milestone reflects the dedication and collaboration of our team, guiding our green philosophy every day to manufacture hi-quality botanical ingredients for pharma, nutraceutical and cosmetic markets. In this ESG Report, you'll learn a lot about that spirit—Linnea's Green Spirit—as it is reflected in everything we do. At its core is respect: ✅ for the Environment that surrounds us and our local communities; ✅ for the People we collaborate with, whether they are employees within our Swiss facilities or are part of the larger Linnea universe; ✅ for the Business world, in the way we operate and create ingredients for our customers' pharmaceutical, dietary and cosmetic products. 🌱Stay tuned for the official publication of the 2024 Linnea ESG Report, where we will share our comprehensive sustainability initiatives and progress. → Read more about the Linnea Green Spirit on our website: https://lnkd.in/dhanMRMh #Linnea #LinneaPharma #ESGReport2024 #SustainableBusiness #GreenSpirit #CorporateResponsibility #PharmaSustainability #LinneaQuality

The Linnea team has just returned from Riyadh, the incredible city which hosted CPHI Middle East, back after a few years' hiatus. And what a comeback it was: we couldn't have asked for a better trade show, proving once again to be an essential occasion to meet potential partners and B2B clients in the Middle East. The entire region is looking to the future, positioning itself as a place where innovation and standards of excellence go hand-in-hand. And where quality is a priority, Linnea feels right at home. Whether you're just back from CPHI Middle East or couldn't make it this year, you can learn more about Linnea's 5 steps of quality on our website:  → https://lnkd.in/djiwvx3i 📌See you next year, this time at our booth where we will be proudly welcoming you as exhibitor! #Linnea #LinneaPharma #CPHIMiddleEast2024 #PharmaceuticalExhibition #PharmaInnovation #QualityPharmaceuticals #MiddleEastPharma #LinneaQuality CPHI CPHI Middle East

CPHI Middle East starts today in Riyadh and our sales team is on-site, bringing the company's 40 years of experience and the reliability of Swiss manufacturing to the region's most comprehensive pharma gathering. Quality is our measure of excellence. More than a motto, it's a credo that has driven us to become fully vertically integrated in our supply chain with our facilities in Australia, where this plant originated. The result is guaranteed quality for Linnea's Butylscopolamine, which is suitable for oral and injectable pharmaceutical uses. At CPHI in Riyadh?  We can't wait to tell you more about the Linnea approach.  → Get in touch with our team: sales@linnea.ch Can't make it this year?  → Learn about Linnea® APIs online: www.linnea.ch/ingredients #Linnea #LinneaPharma #CPHIMiddleEast2024 #PharmaceuticalExhibition #Butylscopolamine #SwissPharma #GMPManufacturing #PharmaInnovation CPHI CPHI Middle East

It's almost time for CPHI Middle East! In just a few days, from December 10th to 12th, the Linnea team will be in Riyadh for this industry conference and exhibition. We'll be sure to hit the ground running, with meetings and lots to see and learn. Of course, our team will bring its portfolio of expertise and knowledge about active pharmaceutical ingredients, including Linnea® Butylscopolamine. Produced in our GMP-certified manufacturing facilities in Switzerland, Linnea has made pharmaceutical grade Butylscopolamine since 1985, obtaining this semi-synthetic derivative from the leaves of Duboisia plants grown at our partner GACP-compliant farm in Australia. Full control over the value chain and verticalization ensure that Linnea® Butylscopolamine is consistent, high-quality and always in stock. Available in oral and injectable grades, Butylscopolamine is a peripherally-acting antimuscarinic and anticholinergic agent with a wide range of therapeutic applications, commonly used to manage motion sickness, postoperative nausea, and specific neurological disorders. Heading to CPHI Middle East? → Book an appointment with our team of experts: sales@linnea.ch → Learn more about Linnea® Butylscopolamine: https://lnkd.in/dHphAKwD #Linnea #LinneaPharma #CPHIMiddleEast2024 #PharmaceuticalExhibition #Butylscopolamine #ActivePharmaceuticalIngredients #GMPManufacturing #PharmaInnovation CPHI CPHI Middle East

A thank you to all who attended CPHI India in Delhi last week! Our sales team was delighted to discuss Linnea products with so many of you, including Linnea's Cannabinoid APIs for the pharmaceutical, dietary and cosmetic industries. It was a true pleasure to expand our network in India, a market that is sharply focused on innovation and the pharma trends of the future. → Learn more about our portfolio: www.linnea.ch → Book an appointment with our team of experts to find out how our ingredients can make a difference in your products: sales@linnea.ch #Linnea #LinneaPharma #CPHIIndia2024 #PharmaceuticalIndustry #CannabinoidAPIs #PharmaInnovation #LinneaProducts #IndiaPharmaMarket CPHI CPHI & PMEC India

Back after years of hiatus, CPHI Middle East will be taking place in Riyadh from December 10th to 12th, and Linnea will be there visiting the event. As the premier exhibition in the region, supported by the Ministry of Health of Saudi Arabia, the event brings the local and global pharma industry together, gathering key players in one of the world's largest regional markets. The Linnea team will bring Swiss excellence to the trade fair, ready to talk about its high-quality APIs such as Butylscopolamine, derived from its plantation of Duboisia plants in Australia and produced in its GMP-certified manufacturing facilities in Switzerland, and Red Clover, with a unique profile that balances the plant's main four isoflavones into a fixed ratio. These APIs and others in the Linnea portfolio correspond to industry trends as they are the foundations for natural, botanical-based treatments sought out around the globe. But Linnea goes one step further: its natural products are produced according to the Linnea Green Spirit, a philosophy which reflects the company's founding core values. → Book an appointment in Riyadh with our team of experts: sales@linnea.ch → Learn more about our portfolio and the Linnea Green Spirit: www.linnea.ch #LinneaSA #CPHIMiddleEast2024 #PharmaceuticalExcellence #BotanicalAPIs #GreenSpirit #SwissQuality CPHI CPHI Middle East

Since it was founded, Linnea has ensured that its products meet strict quality standards in order to satisfy the needs of its clients, forming a solid foundation for business relationships based on trust. In line with this approach, Linnea is one of the first companies in the world to have submitted a CEP application for its Cannabidiol (CBD) API, marking an extraordinary milestone for our Switzerland-based brand, manufacturing Cannabis-based APIs since 2016. Requested in early October 2024, following compliance with the new Ph. Eur. monograph, a CEP "Certificate of Suitability” from the European Directorate for the Quality of Medicines and Healthcare (EDQM) would be the natural progression of Linnea's philosophy and a step forward in becoming a market leader in medical cannabinoids. But why is a CEP so important? Emanuela Torrisi, the Regulatory Affairs Manager at Linnea, explains more in this video from CPHI Milan in October 2024: https://lnkd.in/dcyPimD2 → Learn about our CEP application by reading the article on our online magazine: https://lnkd.in/dPyGWYVz → Discover the certification-backed quality of our Cannabis APIs: sales@linnea.ch #LinneaSA #CannabidiolAPI #CEPCertification #PharmaceuticalExcellence #MedicalCannabinoids #QualityStandards emanuela torrisi

The Linnea sales team couldn't be more excited to take part in CPHI India in Delhi, starting today! With them, we're bringing Linnea's unique approach based on trust and an unwavering commitment to the world's highest standards. Since 1982, Linnea has made natural extracts in its GMP-certified facilities in Switzerland, meeting the strict quality requirements of the pharmaceutical industry. Our portfolio is composed of exclusive products that are unlike any others on the market, known for their high-quality raw materials sourced from GACP-compliant farms, such as our Butylscopolamine extracted from Duboisia leaves coming from our own plantation in Australia, or our Red Clover extract and HMRlignan®. Once picked, each and every raw ingredient is processed in our proprietary GMP plant based in Ticino, Switzerland. Today, Linnea ingredients are used by over 300 clients in 70 countries around the globe.   Are you attending CPHI India and curious about how we can help your pharmaceutical company truly stand out? → Stop by booth #2C37 and talk to our team of experts! #LinneaSA #CPHIIndia2024 #NaturalExtracts #PharmaceuticalExcellence #GMPCertified #GlobalPharma CPHI CPHI & PMEC India

Last week, Linnea attended the Making Cosmetics and in-Vitality co-events to learn more about market trends across global regions and connect with the professionals who are bringing innovation to the industry. Working from our Swiss Headquarters, the Linnea R&D team is committed to constantly delivering dietary and cosmetic ingredients focused on outstanding quality standards, backed by over 40 years of experience in the manufacture of pharma-grade products. Our present and long-term goal is to improve people's lives through research, developing increasingly effective solutions for tomorrow's leading cosmetic, dietary and nutraceutical industries. → Discover our philosophy and portfolio: www.linnea.ch → Learn how our ingredients can enhance your brand's cosmetic and dietary products: → DM us or email sales@linnea.ch #LinneaSA #MakingCosmetics2024 #inVitality2024 #BotanicalIngredients #PharmaGrade #InnovationInHealth